SC
CORT icon

Syon Capital’s Corcept Therapeutics CORT Stock Holding History

Syon Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$532K Sell
6,115
-39
-0.6% -$2.35K 0.02% 603
2026
Q1 		$248K Sell
6,154
-1,124
-15% -$42K 0.01% 801
2025
Q4 		$253K Hold
7,278
– – 0.01% 792
2025
Q3 		$605K Sell
7,278
-128
-2% -$9.26K 0.03% 422
2025
Q2 		$544K Hold
7,406
– – 0.04% 350
2025
Q1 		$846K Buy
7,406
+558
+8% +$34K 0.07% 215
2024
Q4 		$345K Buy
6,848
+717
+12% +$37.6K 0.03% 367
2024
Q3 		$284K Buy
+6,131
New +$218K 0.03% 370
2024
Q1 		– Sell
-6,307
Closed -$205K – 459
2023
Q4 		$205K Buy
+6,307
New +$173K 0.02% 427

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Syon Capital's CORT Position: Q2 2026 in Review

Syon Capital reduced its Corcept Therapeutics (CORT) stake by 0.63% in Q2 2026, selling an estimated $2.35K and leaving 6,115 shares worth $532K. The position accounts for 0.02% of the portfolio, ranked #603.

Syon Capital first reported a position in CORT in Q4 2023 and has held it in 9 quarters since. The position peaked at $846K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Syon Capital held 6,115 shares of Corcept Therapeutics worth $532K as of Q2 2026.
  • Syon Capital sold 39 Corcept Therapeutics shares in Q2 2026, an estimated $2.35K.
  • Corcept Therapeutics made up 0.02% of Syon Capital's portfolio in Q2 2026, its #603 holding.
  • Syon Capital first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • Syon Capital's Corcept Therapeutics position peaked at $846K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.